

Christina Lake signs non-binding LOI for a proposed $15M acquisition of all its shares, subject to due diligence, debt repayment and definitive agreement

Vancouver, British Columbia – February 24, 2026 – TheNewswire - Pursuant to the early warning requirements of applicable Canadian securities laws, Salvatore Milia reports that he, has acquired ownership and direction or control on a direct and indirect basis over an additional 5,030,000 common shares (the “Common Shares”) of Christina Lake Cannabis Corp. (the “Company”) since the filing of an updated early warning report dated December 12, 2025. Since the last early warning report, the Common Shares were acquired between December 13, 2025 and February 23, 2026 at prices ranging from $0.03 to $0.04 per Common Share for aggregate consideration of approximately $163,525.

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has completed a sale of its 99 acres of non-core land at 46 Ponderosa Drive in Christina Lake, British Columbia (the "Land"). Pursuant to the sale of the Land, the Company sold the bare un-serviced Land to an arm's length third party for aggregate gross proceeds of $551,000 (the "Sale Transaction").

Vancouver, British Columbia – TheNewswire - December 12, 2025 – Pursuant to the early warning requirements of applicable Canadian securities laws, Salvatore Milia reports that he and the Milia 2008 Family Trust (the “Trust”), of which Mr. Milia is a trustee, have acquired ownership and direction or control over an additional 5,440,541 common shares (the “Common Shares”) of Christina Lake Cannabis Corp. (CSE:CLC) (the “Company”) since the filing of his initial early warning report dated December 4, 2024. Since the initial early warning report, the Common Shares were acquired between April 30, 2025 and December 10, 2025 at prices ranging from $0.035 to $0.050 per Common Share for aggregate consideration of approximately $262,117.05.

VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that further to the press release dated August 22, 2025, the holders (the "Holders") of convertible debentures in the principal amount of $710,000 (the "Debentures") have entered into amending agreements to amend the terms of the Debentures of the company issued on September 7, 2022.

VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has initiated the process to amend the terms of an aggregate of $960,000 principal amount of convertible debenture (the "Debentures") of the company issued on September 7, 2022 and October 14, 2022. Further details of the terms of the Debentures can be found in the press release of the Company dated September 7, 2022 and October 18, 2022.

VANCOUVER, British Columbia, July 04, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is pleased to confirm that further to its news release dated July 2, 2025, the Company has filed on SEDAR+ its audited financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended February 28, 2025 (the “Annual Filings”). The Annual Filings can be obtained on the Company's SEDAR+ profile at www.sedarplus.ca.

VANCOUVER, British Columbia, July 03, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) announced today that it will not be filing its annual financial statements, accompanying management's discussion and analysis and related chief executive officer ("CEO") and chief financial officer ("CFO") certifications for the financial year ended February 28, 2025 (collectively, the "Annual Filings"), within the period prescribed for the filing of such documents under Parts 4, 5 and 6 of National Instrument 51-102 Continuous Disclosure Obligations and pursuant to National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings, namely within 120 days of year-end, being June 30, 2025 (the "Filing Deadline").
No recent filings indexed.